The estimated Net Worth of Michael A. Gaul is at least 34.1 千$ dollars as of 16 November 2023. Mr Gaul owns over 10,000 units of Beyond Air stock worth over 34,105$ and over the last 9 years he sold XAIR stock worth over 0$.
Mr has made over 6 trades of the Beyond Air stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of XAIR stock worth 17,700$ on 16 November 2023.
The largest trade he's ever made was buying 10,000 units of Beyond Air stock on 16 November 2023 worth over 17,700$. On average, Mr trades about 2,377 units every 258 days since 2016. As of 16 November 2023 he still owns at least 88,150 units of Beyond Air stock.
You can see the complete history of Mr Gaul stock trades at the bottom of the page.
Michael A. Gaul is the Sr. VP of Operations at Beyond Air.
Mr Gaul is 65, he's been the Sr. VP of Operations of Beyond Air since . There are no older and 12 younger executives at Beyond Air.
Michael's mailing address filed with the SEC is C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530.
Over the last 5 years, insiders at Beyond Air have traded over 4,582,444$ worth of Beyond Air stock and bought 3,519,117 units worth 12,396,434$ . The most active insiders traders include Robert Carey、Steven A. Lisi、Amir Avniel. On average, Beyond Air executives and independent directors trade stock every 17 days with the average trade being worth of 15,492$. The most recent stock trade was executed by Steven A. Lisi on 15 August 2024, trading 50,000 units of XAIR stock currently worth 18,500$.
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Beyond Air executives and other stock owners filed with the SEC include: